Charming Medical (MCTA) Current Deferred Revenue (2024 - 2026)

Charming Medical has disclosed Current Deferred Revenue across 3 years of filings, most recently posting $3.0 million for Q1 2026.

• In Q1 2026, Current Deferred Revenue fell 12.01% year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at $3.0 million (down 12.01% YoY), while the FY2026 annual figure was $3.0 million, down 12.01% from the prior year.
• Current Deferred Revenue came in at $3.0 million for Q1 2026 at Charming Medical, down from $3.7 million in the prior quarter.
• In the past five years, Current Deferred Revenue ranged from a high of $4.5 million in Q1 2024 to a low of $3.0 million in Q1 2026.
• Average Current Deferred Revenue over 3 years is $3.7 million, with a median of $3.6 million recorded in 2025.
• Year-over-year, Current Deferred Revenue retreated 22.97% in 2025 and fell 12.01% in 2026.
• Over 3 years, Current Deferred Revenue stood at $4.5 million in 2024, then slipped by 17.31% to $3.7 million in 2025, then declined by 18.03% to $3.0 million in 2026.
• Per Business Quant data, the three most recent Current Deferred Revenue figures were $3.0 million in Q1 2026, $3.7 million in Q3 2025, and $3.5 million in Q1 2025.